
Laura Lynne Stockton
Examiner (ID: 6934)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 2899, 1613, 1201, 1614, 1646, 1626 |
| Total Applications | 3246 |
| Issued Applications | 2197 |
| Pending Applications | 344 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5154889
[patent_doc_number] => 20070037772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Pyrazolidinol compounds'
[patent_app_type] => utility
[patent_app_number] => 11/371226
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5787
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037772.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371226 | Pyrazolidinol compounds | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5667711
[patent_doc_number] => 20060173061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'New beta-agonists, processes for preparing them and their use as pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/276649
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10179
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20060173061.pdf
[firstpage_image] =>[orig_patent_app_number] => 11276649
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/276649 | Beta-agonists, processes for preparing them and their use as pharmaceutical compositions | Mar 8, 2006 | Issued |
Array
(
[id] => 5760801
[patent_doc_number] => 20060211746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Desferrithiocin derivatives and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/367042
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6720
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11367042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/367042 | Desferrithiocin derivatives and methods of use thereof | Mar 1, 2006 | Issued |
Array
(
[id] => 5632405
[patent_doc_number] => 20060148875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Agent for prophylaxis and treatment of diabetic complications'
[patent_app_type] => utility
[patent_app_number] => 11/363202
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4967
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11363202
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/363202 | Agent for prophylaxis and treatment of diabetic complications | Feb 27, 2006 | Abandoned |
| 11/364795 | Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging | Feb 26, 2006 | Abandoned |
Array
(
[id] => 9827956
[patent_doc_number] => 08937184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-20
[patent_title] => '1H-imidazole derivatives as cannabinoid CB2 receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 11/353155
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13442
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11353155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353155 | 1H-imidazole derivatives as cannabinoid CB2 receptor modulators | Feb 13, 2006 | Issued |
Array
(
[id] => 5683552
[patent_doc_number] => 20060199822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/349352
[patent_app_country] => US
[patent_app_date] => 2006-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28017
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11349352
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/349352 | Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors | Feb 7, 2006 | Issued |
Array
(
[id] => 5656629
[patent_doc_number] => 20060142365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Benzimidazole compounds and antiviral uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/346758
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29497
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346758
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346758 | Benzimidazole compounds and antiviral uses thereof | Feb 1, 2006 | Abandoned |
Array
(
[id] => 5913722
[patent_doc_number] => 20060128784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Bis-heteroaryl alkanes as therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/345065
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12393
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128784.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345065 | Bis-heteroaryl alkanes as therapeutic agents | Jan 31, 2006 | Abandoned |
Array
(
[id] => 5374742
[patent_doc_number] => 20090312303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Antidiabetic Bicyclic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/794705
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29488
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794705
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794705 | Antidiabetic bicyclic compounds | Jan 29, 2006 | Issued |
Array
(
[id] => 4894086
[patent_doc_number] => 20080103185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Process for Producing Thiazolidinedione Compound and Production Intermediate Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/795270
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11292
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103185.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795270
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795270 | Process for Producing Thiazolidinedione Compound and Production Intermediate Thereof | Jan 23, 2006 | Abandoned |
Array
(
[id] => 5875466
[patent_doc_number] => 20060167058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'PPAR-activating compound'
[patent_app_type] => utility
[patent_app_number] => 11/335669
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10187
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167058.pdf
[firstpage_image] =>[orig_patent_app_number] => 11335669
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/335669 | PPAR-activating compound | Jan 19, 2006 | Issued |
Array
(
[id] => 5586048
[patent_doc_number] => 20090105250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/814912
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15454
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814912 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | Jan 18, 2006 | Abandoned |
Array
(
[id] => 5705810
[patent_doc_number] => 20060194858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Preparation of crude candesartan cilexetil'
[patent_app_type] => utility
[patent_app_number] => 11/333875
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2291
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11333875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/333875 | Preparation of crude candesartan cilexetil | Jan 16, 2006 | Abandoned |
Array
(
[id] => 817263
[patent_doc_number] => 07411071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/330748
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16170
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/411/07411071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330748 | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Jan 11, 2006 | Issued |
Array
(
[id] => 4873795
[patent_doc_number] => 20080200529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Novel 2-Amino Benzimidazole Derivatives and Their Use As Modulators Of Small-Conductance Calcium-Activated Potassium Channels'
[patent_app_type] => utility
[patent_app_number] => 11/795018
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9067
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200529.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795018 | 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels | Jan 9, 2006 | Issued |
Array
(
[id] => 5632408
[patent_doc_number] => 20060148878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Pseudopolymorphic forms of carvedilol'
[patent_app_type] => utility
[patent_app_number] => 11/325754
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6452
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148878.pdf
[firstpage_image] =>[orig_patent_app_number] => 11325754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/325754 | Pseudopolymorphic forms of carvedilol | Jan 4, 2006 | Abandoned |
Array
(
[id] => 5626125
[patent_doc_number] => 20060264630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Substituted phenylacetic acids'
[patent_app_type] => utility
[patent_app_number] => 11/326616
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 75795
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264630.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326616
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326616 | Substituted phenylacetic acids | Jan 3, 2006 | Issued |
Array
(
[id] => 112846
[patent_doc_number] => 07714005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Small molecule Bcl-xL/Bcl-2 binding inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/315077
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12042
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/714/07714005.pdf
[firstpage_image] =>[orig_patent_app_number] => 11315077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/315077 | Small molecule Bcl-xL/Bcl-2 binding inhibitors | Dec 21, 2005 | Issued |
Array
(
[id] => 5694827
[patent_doc_number] => 20060154974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'N-thiazol-2-yl-benzamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/312661
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18372
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154974.pdf
[firstpage_image] =>[orig_patent_app_number] => 11312661
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/312661 | N-thiazol-2-yl-benzamide derivatives | Dec 19, 2005 | Abandoned |